• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尼鲁单抗治疗难治性肥厚性盘状红斑狼疮疗效显著。

Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab.

机构信息

Rheumatology, Rochester Regional Health, Rochester, New York, USA

Rheumatology, URMC, Rochester, New York, USA.

出版信息

BMJ Case Rep. 2024 Jun 18;17(6):e258487. doi: 10.1136/bcr-2023-258487.

DOI:10.1136/bcr-2023-258487
PMID:38890107
Abstract

Hypertrophic discoid lupus erythematosus is a rare variant of chronic cutaneous lupus erythematosus and is often challenging to treat. A male in his early 60s presented with diffuse erythematous, crusty, pruritic plaques on his upper and lower extremities, face, upper back, dorsal aspect of the hands and chest. He also described prolonged morning stiffness, swelling of his fingers and wrists, oral sores and Raynaud's phenomenon. He was positive for antinuclear antibody and anti-SSA antibody and had low C3 and C4 proteins. The skin biopsy was consistent with hypertrophic discoid lupus erythematosus. He was diagnosed with systemic lupus erythematosus. Skin lesions were refractory to treatment with topical corticosteroids, topical acitretin, hydroxychloroquine, azathioprine or mycophenolate. Anifrolumab infusions were initiated with a near-complete resolution of cutaneous symptoms within 3 months.

摘要

肥厚性盘状红斑狼疮是慢性皮肤型红斑狼疮的一种罕见变异,治疗起来往往具有挑战性。一位 60 岁出头的男性患者上肢、下肢、面部、上背部、手部背侧和胸部出现弥漫性红斑、结痂、瘙痒斑块。他还描述了晨僵时间延长、手指和手腕肿胀、口腔溃疡和雷诺现象。他的抗核抗体和抗 SSA 抗体呈阳性,C3 和 C4 蛋白水平较低。皮肤活检结果符合肥厚性盘状红斑狼疮。他被诊断为系统性红斑狼疮。皮肤病变对局部皮质类固醇、局部阿维 A、羟氯喹、硫唑嘌呤或霉酚酸酯治疗反应不佳。阿尼鲁单抗治疗开始后,3 个月内皮肤症状几乎完全缓解。

相似文献

1
Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab.阿尼鲁单抗治疗难治性肥厚性盘状红斑狼疮疗效显著。
BMJ Case Rep. 2024 Jun 18;17(6):e258487. doi: 10.1136/bcr-2023-258487.
2
Efficacy of anifrolumab in long-term intractable alopecia due to discoid lupus erythematosus.阿尼鲁单抗治疗盘状红斑狼疮所致长期难治性脱发的疗效。
Mod Rheumatol Case Rep. 2024 Jul 8;8(2):267-271. doi: 10.1093/mrcr/rxae018.
3
Treatment With Anifrolumab for Discoid Lupus Erythematosus.阿尼鲁单抗治疗盘状红斑狼疮
JAMA Dermatol. 2023 Feb 1;159(2):224-226. doi: 10.1001/jamadermatol.2022.5242.
4
Drugs for discoid lupus erythematosus.用于盘状红斑狼疮的药物。
Cochrane Database Syst Rev. 2017 May 5;5(5):CD002954. doi: 10.1002/14651858.CD002954.pub3.
5
Anifrolumab for Adolescent Discoid Lupus Erythematosus.阿尼鲁单抗治疗青少年盘状红斑狼疮
JAMA Netw Open. 2023 Oct 2;6(10):e2338200. doi: 10.1001/jamanetworkopen.2023.38200.
6
Response to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupus.对同时患有严重银屑病和肥厚性皮肤狼疮的患者使用乌司奴单抗的疗效。
Lupus. 2012 Aug;21(9):1007-10. doi: 10.1177/0961203312441982. Epub 2012 Mar 21.
7
Drugs for discoid lupus erythematosus.用于盘状红斑狼疮的药物。
Cochrane Database Syst Rev. 2009 Oct 7(4):CD002954. doi: 10.1002/14651858.CD002954.pub2.
8
Hypertrophic and ulcerated discoid lupus erythematosus.肥厚性和溃疡性盘状红斑狼疮。
J Cutan Med Surg. 2012 Nov-Dec;16(6):453-7. doi: 10.1177/120347541201600620.
9
Treatment of discoid lupus with lenalidomide and anifrolumab: Case report and review of the literature.来那度胺和阿尼鲁单抗治疗盘状狼疮:病例报告及文献复习。
Lupus. 2024 Nov;33(13):1487-1491. doi: 10.1177/09612033241289489. Epub 2024 Oct 7.
10
Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus.难治性盘状红斑狼疮患者对阿尼鲁单抗临床反应的评估
JAMA Dermatol. 2023 May 1;159(5):560-563. doi: 10.1001/jamadermatol.2023.0175.

引用本文的文献

1
Anifrolumab for Nonsystemic Cutaneous Lupus Erythematosus: Clinical Experience, Immunologic Insights, and Review of the Literature.阿尼鲁单抗治疗非系统性皮肤红斑狼疮:临床经验、免疫学见解及文献综述
J Clin Med. 2025 Aug 11;14(16):5683. doi: 10.3390/jcm14165683.
2
Treatment of recalcitrant discoid lupus erythematosus with roflumilast 0.3% cream following suboptimal response to anifrolumab and improvement of hypopigmentation.在对阿尼鲁单抗反应欠佳后,使用0.3%罗氟司特乳膏治疗顽固性盘状红斑狼疮及色素减退改善情况
JAAD Case Rep. 2024 Oct 9;54:50-52. doi: 10.1016/j.jdcr.2024.09.016. eCollection 2024 Dec.